Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Biomarker And Lab-Based Prediction Scores
Interactive worksheet1 clinical inputsPatient data not stored

MR-proADM Index Calculator

MR-proADM Index: Explanation and Clinical Context Midregional proadrenomedullin (MR-proADM) is a stable fragment of adrenomedullin precursor, a peptide involved in vasodilation, endothelial function, and cardiovascular homeostasis. It serves as a biomarker for cardiovascular and sepsis-related risk, reflecting disease severity and predicting adverse outcomes. Clinical studies have shown that MR-proADM levels correlat

Interactive worksheet

Clinical inputs

0/1 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

MR-proADM Index: Explanation and Clinical Context Midregional proadrenomedullin (MR-proADM) is a stable fragment of adrenomedullin precursor, a peptide involved in vasodilation, endothelial function, and cardiovascular homeostasis. It serves as a biomarker for cardiovascular and sepsis-related risk, reflecting disease severity and predicting adverse outcomes. Clinical studies have shown that MR-proADM levels correlate with prognosis in patients with heart failure, acute coronary syndrome, and sepsis.

Risk stratification based on MR-proADM (nmol/L): - < 0.75 nmol/L: Low risk - 0.75–1.5 nmol/L: Intermediate risk - > 1.5 nmol/L: High risk This index helps clinicians identify patients at higher risk for adverse cardiovascular events and mortality, guiding monitoring intensity and therapeutic decisions.

Evidence & references1 primary source mapped
  1. Source 1

    Schuetz P, Christ-Crain M, Morgenthaler NG, et al. Mid-regional pro-adrenomedullin improves risk stratification in patients with community-acquired pneumonia. Eur Heart J. 2010;31:2907-2916. doi:10.1093/eurheartj/ehq204

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

Systemic Immune-Inflammation Index (SII) Calculator

Biomarker And Lab-Based Prediction Scores
Interactive worksheet

LDL/ApoB Ratio (Atherogenic Risk) Calculator

Biomarker And Lab-Based Prediction Scores
Interactive worksheet

CRP/Albumin Ratio (CAR) Calculator

Biomarker And Lab-Based Prediction Scores
Interactive worksheet

Troponin-CK-MB Concordance Index Calculator

Biomarker And Lab-Based Prediction Scores
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.